News

Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol

Dr Toh Tan Boon’s team is excited to share their latest clinical trial protocol in PLOS ONE, “Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol”.

Read More: Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol – PLOS ONE

view MORE related

News

2026
WisDM Translational Core (Tx) Laboratory Researchers Recognised at NCAM 2026
More Details >
2026
From conversations to code: NUS researchers craft age-friendly tech with the community at heart
More Details >
2026
Winner of Lilly Medal and Prize in Pharmacology 2026
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg